Bernard Beryl Brodie (7 August 1907 – 28 February 1989) was a founding scientist in the area of biochemical and neurochemical pharmacology whose work in the 1940s and 1950s had great impact.

Brodie developed methods for measurement of drug metabolism, disposition, and response, which enabled him to generalize from experimental data to underlying principles and concepts.

During World War II, Brodie played a key role at the Goldwater Research Service group at NYU, led by James A.

[2] During World War II, Brodie and others in the Goldwater Research Service group at NYU were tasked by James A. Shannon with developing an effective antimalarial therapy for use by allied troops.

In January, 1947, he published several papers, based on the atabrine work, that described general principles for the separation and accurate measurement of drugs and their metabolites.

[3] Together with Julius Axelrod, Brodie discovered how two popular headache remedies of the day were causing the illness methemoglobinemia, a non-lethal blood condition.

[8] The biography, Apprentice to Genius by Robert Kanigel, describes Brodie's scientific career and the impact he had on a group of scientists who have gone on to make prize-winning breakthroughs in biomedical science.

[3] In 1967, Brodie received the Albert Lasker Award for Basic Medical Research for more than 30 years of work resulting in "extraordinary contributions to biochemical pharmacology.